BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24051572)

  • 1. Short stature before puberty: which children should be screened for SHOX deficiency?
    Wolters B; Lass N; Wunsch R; Böckmann B; Austrup F; Reinehr T
    Horm Res Paediatr; 2013; 80(4):273-80. PubMed ID: 24051572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature.
    Binder G; Ranke MB; Martin DD
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4891-6. PubMed ID: 14557470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.
    Rappold GA; Fukami M; Niesler B; Schiller S; Zumkeller W; Bettendorf M; Heinrich U; Vlachopapadoupoulou E; Reinehr T; Onigata K; Ogata T
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1402-6. PubMed ID: 11889216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity.
    Binder G; Renz A; Martinez A; Keselman A; Hesse V; Riedl SW; Häusler G; Fricke-Otto S; Frisch H; Heinrich JJ; Ranke MB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4403-8. PubMed ID: 15356038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.
    Binder G; Schwarze CP; Ranke MB
    J Clin Endocrinol Metab; 2000 Jan; 85(1):245-9. PubMed ID: 10634394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence of SHOX gene deletion in children with idiopathic short stature. A multicentric study].
    Dávid A; Butz H; Halász Z; Török D; Nyirő G; Muzsnai Á; Csákváry V; Luczay A; Sallai Á; Hosszú É; Felszeghy E; Tar A; Szántó Z; Fekete GL; Kun I; Patócs A; Bertalan R
    Orv Hetil; 2017 Aug; 158(34):1351-1356. PubMed ID: 28823207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.
    Donze SH; Meijer CR; Kant SG; Zandwijken GR; van der Hout AH; van Spaendonk RM; van den Ouweland AM; Wit JM; Losekoot M; Oostdijk W
    Eur J Endocrinol; 2015 Nov; 173(5):611-21. PubMed ID: 26264720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.
    Jorge AA; Souza SC; Nishi MY; Billerbeck AE; Libório DC; Kim CA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):130-5. PubMed ID: 17201812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
    Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
    J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SHOX haploinsufficiency among short statured children.
    Marstrand-Joergensen MR; Jensen RB; Aksglaede L; Duno M; Juul A
    Pediatr Res; 2017 Feb; 81(2):335-341. PubMed ID: 27814343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SHOX gene and the short stature. Roundtable on diagnosis and treatment of short stature due to SHOX haploinsufficiency: how genetics, radiology and anthropometry can help the pediatrician in the diagnostic process Padova (April 20th, 2011).
    De Sanctis V; Tosetto I; Iughetti L; Antoniazzi F; Clementi M; Toffolutti T; Facchin P; Monti E; Pisanello L; Tonini G; Greggio NA
    Pediatr Endocrinol Rev; 2012 Aug; 9(4):727-33. PubMed ID: 23304810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature).
    Caliebe J; Broekman S; Boogaard M; Bosch CA; Ruivenkamp CA; Oostdijk W; Kant SG; Binder G; Ranke MB; Wit JM; Losekoot M
    Horm Res Paediatr; 2012; 77(4):250-60. PubMed ID: 22572840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius.
    Soucek O; Zapletalova J; Zemkova D; Snajderova M; Novotna D; Hirschfeldova K; Plasilova I; Kolouskova S; Rocek M; Hlavka Z; Lebl J; Sumnik Z
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1241-7. PubMed ID: 23666967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypes and phenotypes of children with SHOX deficiency in France.
    Rosilio M; Huber-Lequesne C; Sapin H; Carel JC; Blum WF; Cormier-Daire V
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1257-65. PubMed ID: 22518848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency.
    Rappold G; Blum WF; Shavrikova EP; Crowe BJ; Roeth R; Quigley CA; Ross JL; Niesler B
    J Med Genet; 2007 May; 44(5):306-13. PubMed ID: 17182655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
    Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
    Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis.
    Malaquias AC; Scalco RC; Fontenele EG; Costalonga EF; Baldin AD; Braz AF; Funari MF; Nishi MY; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
    Horm Res Paediatr; 2013; 80(6):449-56. PubMed ID: 24296787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.